Clinical Trial Update: Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating the safety of intrathecal transplantation of human glial restricted progenitor cells (Q-Cells) in adults with amyotrophic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Q-Cells (human glial restricted progenitor cells) (human glial restricted progenitor cells)

Snippet

Sponsor: Q Therapeutics, Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN